ANAVEX New Website - Untitled Page.png

News, Events and Updates

Search
Anavex Life Sciences Provides Business Update & Reports Fiscal 2022 Second Quarter Financial Results
  • 6 days ago

Anavex Life Sciences Provides Business Update & Reports Fiscal 2022 Second Quarter Financial Results

Anavex Life Sciences to Announce Fiscal 2022 Second Quarter Financial Results on Tues. May 10, 2022
  • May 3

Anavex Life Sciences to Announce Fiscal 2022 Second Quarter Financial Results on Tues. May 10, 2022

Anavex Life Sciences Announces Presentations at the IRSF Rett Syndrome Scientific Meeting
  • Apr 27

Anavex Life Sciences Announces Presentations at the IRSF Rett Syndrome Scientific Meeting

Anavex Life Sciences Invited to Present at a Neuro & Ophthalmology Conference
  • Apr 26

Anavex Life Sciences Invited to Present at a Neuro & Ophthalmology Conference

Anavex Life Sciences to Present at the Needham Virtual Healthcare Conference
  • Apr 7

Anavex Life Sciences to Present at the Needham Virtual Healthcare Conference

Anavex Life Sciences to Participate in the Cantor Virtual Rare Orphan Disease Summit
  • Mar 28

Anavex Life Sciences to Participate in the Cantor Virtual Rare Orphan Disease Summit

Anavex Life Sciences Announces Presentation of Phase 2 Clinical Biomarker Data from PDD study
  • Mar 15

Anavex Life Sciences Announces Presentation of Phase 2 Clinical Biomarker Data from PDD study

Anavex Life Sciences to Participate in the Annual Needham Virtual Neuroscience Forum
  • Mar 9

Anavex Life Sciences to Participate in the Annual Needham Virtual Neuroscience Forum

Anavex Life Sciences Announces Change of Auditor to Grant Thornton LLP
  • Mar 4

Anavex Life Sciences Announces Change of Auditor to Grant Thornton LLP

Anavex Life Sciences to Present at the 11th Annual SVB Leerink Global Healthcare Conference
  • Feb 10

Anavex Life Sciences to Present at the 11th Annual SVB Leerink Global Healthcare Conference

Anavex Life Sciences Provides Business Update & Reports Fiscal 2022 First Quarter Financial Results
  • Feb 9

Anavex Life Sciences Provides Business Update & Reports Fiscal 2022 First Quarter Financial Results

1
2345

Stay Connected

Follow us on social media

  • Twitter
  • LinkedIn
  • Instagram
  • Facebook
Newsroom
Webcast Library
Contact Us
Back to Newsroom

Quick Links

Home

Therapeutic Candidates

Investors

News

Patients & Carers

Contact Us

Resources

About Us

SIGMACEPTOR™ 

Corporate Presentation

Forward-Looking Statements

Legal Notice

Privacy Policy

New Logo white .png

Join our mailing list

Thank you for subscribing!

ANAVEX® is a trademark of Anavex Life Sciences Corp. © 2007-2022. All Rights Reserved.